|
Myeloid Neoplasia
Citations 51-60 of 176 total displayed.
|
Past content
(since Jan 2009):
|
BCR-ABL promotes the frequency of mutagenic single-strand annealing DNA repair
- Margret S. Fernandes, Mamatha M. Reddy, Jeffrey R. Gonneville, Scott C. DeRoo, Klaus Podar, James D. Griffin, David M. Weinstock, and Martin Sattler
Blood 2009; 114: 1813-1819.
[Abstract]
[Full text]
[PDF]
ID1 promotes expansion and survival of primary erythroid cells and is a target of JAK2V617F-STAT5 signaling
- Andrew D. Wood, Edwin Chen, Ian J. Donaldson, Shilpa Hattangadi, Karly A. Burke, Mark A. Dawson, Diego Miranda-Saavedra, Harvey F. Lodish, Anthony R. Green, and Berthold Göttgens
Blood 2009; 114: 1820-1830.
[Abstract]
[Full text]
[PDF]
Enrichment of Sca1+ hematopoietic progenitors in polycythemic mice inhibits leukemogenesis
- Tatiana Usenko, You-Jun Li, Mehran Haeri, Yanmei Li, Laura M. Vecchiarelli-Federico, Xiaojun Zhao, Josef T. Prchal, and Yaacov Ben-David
Blood 2009; 114: 1831-1841.
[Abstract]
[Full text]
[PDF]
Selective reduction of JAK2V617F-dependent cell growth by siRNA/shRNA and its reversal by cytokines
- Abire Jedidi, Caroline Marty, Charleen Oligo, Laurence Jeanson-Leh, Jean-Antoine Ribeil, Nicole Casadevall, Anne Galy, William Vainchenker, and Jean-Luc Villeval
Blood 2009; 114: 1842-1851.
[Abstract]
[Full text]
[PDF]
Metnase mediates chromosome decatenation in acute leukemia cells
- Justin Wray, Elizabeth A. Williamson, Sheema Sheema, Suk-Hee Lee, Edward Libby, Cheryl L. Willman, Jac A. Nickoloff, and Robert Hromas
Blood 2009; 114: 1852-1858.
[Abstract]
[Full text]
[PDF]
Mutations in CBL occur frequently in juvenile myelomonocytic leukemia
- Mignon L. Loh, Debbie S. Sakai, Christian Flotho, Michelle Kang, Manfred Fliegauf, Sophie Archambeault, Charles G. Mullighan, Leslie Chen, Eva Bergstraesser, Carlos E. Bueso-Ramos, Peter D. Emanuel, Henrik Hasle, Jean-Pierre Issa, Marry M. van den Heuvel-Eibrink, Franco Locatelli, Jan Stary, Monica Trebo, Marcin Wlodarski, Marco Zecca, Kevin M. Shannon, and Charlotte M. Niemeyer
Blood 2009; 114: 1859-1863.
[Abstract]
[Full text]
[PDF]
The new tyrosine-kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivo
- Marie-Pierre Gratacap, Valérie Martin, Marie-Cécile Valéra, Sophie Allart, Cédric Garcia, Pierre Sié, Christian Recher, and Bernard Payrastre
Blood 2009; 114: 1884-1892.
[Abstract]
[Full text]
[PDF]
Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele
- Paola Guglielmelli, Giovanni Barosi, Giorgina Specchia, Alessandro Rambaldi, Francesco Lo Coco, Elisabetta Antonioli, Lisa Pieri, Alessandro Pancrazzi, Vanessa Ponziani, Federica Delaini, Giovanni Longo, Emanuele Ammatuna, Vincenzo Liso, Alberto Bosi, Tiziano Barbui, and Alessandro M. Vannucchi
Blood 2009; 114: 1477-1483.
[Abstract]
[Full text]
[PDF]
Repression of BMI1 in normal and leukemic human CD34+ cells impairs self-renewal and induces apoptosis
- Aleksandra Rizo, Sandra Olthof, Lina Han, Edo Vellenga, Gerald de Haan, and Jan Jacob Schuringa
Blood 2009; 114: 1498-1505.
[Abstract]
[Full text]
[PDF]
Programmed death 1 signaling on chronic myeloid leukemia–specific T cells results in T-cell exhaustion and disease progression
- Sabine Mumprecht, Christian Schürch, Juerg Schwaller, Max Solenthaler, and Adrian F. Ochsenbein
Blood 2009; 114: 1528-1536.
[Abstract]
[Full text]
[PDF]
|
|
